α-Glucosidase-IN-27

α-Glucosidase-IN-27

Cat. No.: DIA-0243388

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
Formula C22H20N4O4S
Molecular Weight 436.48
SMILES CC(SC1=NN=C(CC2=CNC3=C2C=CC=C3)O1)C(NC4=CC=CC=C4C(OC)=O)=O
Target Glucosidase
Product Description α-Glucosidase-IN-27 (compound 8l) is an α-glucosidase inhibitor (IC50=25.78 μM). α-Glucosidase-IN-27 has the potential to study type 2 diabetes (D2M).
Format & Storage
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top